‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans’ – Author’s reply.

‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans’ – Author’s reply.

Publication date: Oct 08, 2024

Concepts Keywords
Covid COVID-19
Drugs Long COVID
Microbiol Nirmatrelvir-ritonavir
Older Omicron
Singaporeans SARS-CoV-2

Semantics

Type Source Name
drug DRUGBANK Ritonavir
disease MESH post-acute sequelae of COVID-19
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *